Jasper Therapeutics JSPR Balance Sheet (2019-2026)

NASDAQ JSPR
$0.70 +0.01 (+2.02%)
At close: Sep 10, 2026 · 4:00 PM EDT
Reported Financials

Jasper Therapeutics Quarterly Balance Sheet

Periods 26 quarters
Latest Jun 2026

Jasper Therapeutics reported total assets of $11.80M and total liabilities of $10.39M for the quarter ended Jun 2026, down 79.5% year over year. This balance sheet covers 26 quarters of results from Dec 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Accumulated Depreciation
1.35M1.63M1.90M2.18M2.46M2.75M3.05M3.59M3.81M4.08M3.82M3.90M4.81M4.21M
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
0.31M100.91M84.70M70.40M60.81M50.95M38.25M129.40M115.81M103.90M86.89M118.50M106.82M92.50M71.64M48.80M39.51M50.90M28.69M7.31M
Receivables - OtherOther Receivables
0.15M0.01M0.05M0.12M0.66M-0.66M0.05M0.02M
Prepaid Assets
0.10M1.50M3.13M3.40M2.47M1.46M2.82M3.11M2.75M1.35M2.05M1.83M1.86M2.30M4.17M4.38M3.46M3.67M5.95M3.84M
Current Assets
0.42M102.41M87.83M73.80M63.29M52.41M41.73M132.51M118.57M105.22M88.94M120.31M108.68M94.81M75.81M53.17M42.97M54.56M34.65M11.57M
Non-Current Assets
Property, Plant & Equipment (Net)
3.28M3.69M3.50M4.02M3.76M3.57M3.32M3.06M2.78M2.73M2.46M2.44M2.07M1.88M1.60M1.33M1.10M0.10M0.06M
Long-Term Investments
100.13M
Intangibles
5.00M
Goodwill & Intangibles
5.00M
Long-Term Deferred Tax
0.33M18.00M34.49M46.95M
Other Non-Current Assets
1.50M3.13M3.40M2.47M1.46M0.76M0.72M0.45M0.42M1.34M1.42M1.16M1.01M0.82M0.53M0.42M0.42M0.42M0.04M
Non-Current Assets
100.13M4.81M5.82M6.75M7.08M6.70M6.63M6.25M5.60M5.19M5.95M5.66M5.25M4.61M4.09M4.42M3.50M2.90M1.13M0.23M
Assets
100.55M107.21M93.65M80.55M70.37M59.11M48.36M138.76M124.17M110.41M94.89M125.96M113.93M99.41M79.90M57.60M46.47M57.47M35.78M11.80M
Liabilities
Current Liabilities
Accounts Payables
0.33M8.79M3.92M1.47M3.00M3.12M1.77M3.85M1.58M3.26M4.15M2.39M2.96M3.09M4.03M3.00M8.03M9.17M6.22M2.78M
Payables
0.33M8.79M3.92M1.47M3.00M3.12M1.77M3.85M1.58M3.26M4.15M2.39M2.96M3.09M4.03M3.00M8.03M9.17M6.22M2.78M
Accumulated Expenses
6.42M3.60M3.98M2.84M3.46M4.43M3.15M6.47M7.68M7.25M5.50M6.05M8.31M10.12M7.50M10.51M10.17M5.75M4.80M
Other Accumulated Expenses
0.47M0.58M0.55M0.52M0.82M0.20M0.32M0.45M0.85M0.42M0.44M0.10M0.06M0.12M0.04M
Current Leases
0.49M0.51M0.52M0.78M0.84M0.86M0.89M0.92M0.94M0.97M1.00M1.03M1.06M1.09M1.83M1.95M1.70M1.24M0.27M
Current Taxes
Total Current Liabilities
0.33M9.16M8.02M5.97M6.62M7.42M7.07M7.89M8.97M11.91M12.37M8.92M10.07M12.46M15.24M12.33M20.50M21.04M13.20M7.84M
Non-Current Liabilities
Non-Current Debt
0.02M
Non-Current Deffered Revenue
3.50M
Preferred Stock Liabilities
81.29M
Minority Interest
Operating Leases
2.51M2.38M3.38M3.23M3.85M2.79M2.55M2.32M3.01M1.81M1.55M1.29M1.01M0.72M0.76M0.20M
Non-Current Deferred Tax Liability
0.32M0.56M0.49M
Other Non-Current Liabilities
10.43M7.90M5.74M0.64M0.75M0.71M2.35M2.33M2.31M2.30M2.26M2.26M2.26M2.26M2.30M2.26M2.26M22.59M16.16M2.54M
Total Non-Current Liabilities
3.83M20.71M18.39M11.80M10.84M10.84M10.02M11.23M11.65M13.97M14.19M10.47M11.36M13.47M15.93M13.09M20.70M23.30M15.46M7.84M
Total Liabilities
14.26M28.61M24.14M12.44M11.59M11.54M12.37M13.56M13.96M16.27M16.45M12.73M13.62M15.73M18.23M15.35M22.96M45.90M31.63M10.39M
Shareholder's Equity
Total Debt
0.02M
Common Equity
-52.60M78.60M69.52M68.11M58.78M47.56M35.99M125.20M110.20M94.13M78.44M113.23M100.31M83.68M61.67M42.24M23.50M11.57M4.15M1.41M
Liabilities and Shareholders Equity
100.55M107.21M93.65M80.55M70.37M59.11M48.36M138.76M124.17M110.41M94.89M125.96M113.93M99.41M79.90M57.60M46.47M57.47M35.78M11.80M
Retained Earnings
10.15M136.99M136.96M137.76M138.84M139.49M141.12M244.58M245.67M247.14M248.04M296.56M298.22M300.23M302.54M304.35M312.33M319.14M320.82M322.01M
Treasury Shares
8.13M5.50M0.55M0.55M0.55M0.55M0.55M0.55M0.55M0.55M0.55M0.55M